In a recent study, published in the Journal of Clinical Psychiatry, PTSD patients allowed to choose between therapies ended up costing about $1,622 less on average per patient per year compared with patients who were assigned treatment. Among patients not given a choice, treatment with prolonged exposure psychotherapy cost less on than sertraline.
“This is one of the first studies to look at the cost of providing mental health care and comparing different treatments for PTSD,” said Lori Zoellner, co-author of the study and director of the University of Washington’s Center for Anxiety and Traumatic Stress. “It has tremendous implications for how large health care systems such as the U.S. Department of Veterans Affairs proceed with treating PTSD.”
The National Institute of Mental Health funded the study, with additional funding from the American Association of Colleges of Pharmacy.
http://www.sciencedaily.com/releases/2014/05/140528132703.htm
Abstract in The Journal of Clinical Psychiatry: Cost-Effectiveness of Prolonged Exposure Therapy Versus Pharmacotherapy and Treatment Choice in Posttraumatic Stress Disorder (the Optimizing PTSD Treatment Trial).
Comments (0)